Fierce Biotech1 min read
saveFDA pushes decision on Belite’s eye disease pill back to May
The FDA is taking a little extra time to review Belite Bio’s application for its treatment for a rare genetic eye condition, pushing the expected action date back by three months into May next year.
comments(0)
5-min edit window · permanent after that